Showing results (41-50 of 77) with videos related to

Sort By:
Pageof 8
Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society|September 14, 2023
Augmented antitumor effects of erlotinib and cabozantinib on A549 non-small cell lung cancer: In vitro and in vivo studiesKhalid Alhazzani, Meshal Alsahli, Ahmed Z Alanazi, et al.
Frontiers in Oncology|January 23, 2023
New insight into strategies used to develop long-acting G-CSF biologics for neutropenia therapyAbdulrahman Theyab, Khalaf F Alsharif, Khalid J Alzahrani, et al.
Journal of Inflammation Research|April 23, 2021
Methanolic Fenugreek Seed Extract Induces p53-Dependent Mitotic Catastrophe in Breast Cancer Cells, Leading to ApoptosisFaris A Alrumaihi, Masood A Khan, Khaled S Allemailem, et al.
Platelets|November 18, 2008
DG-041 inhibits the EP3 prostanoid receptor--a new target for inhibition of platelet function in atherothrombotic diseaseStan Heptinstall, David Iyu Espinosa, Panagiotis Manolopoulos, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|June 18, 2021
Targeting allosteric sites of human aromatase: a comprehensive in-silico and in-vitro workflow to find potential plant-based anti-breast cancer therapeuticsHani A Alhadrami, Ahmed M Sayed, Sami A Melebari, et al.
International Immunopharmacology|February 19, 2022
Dysregulated Nrf2 signaling in response to di(2-ethylhexyl) phthalate in neutrophils of children with autismAhmed Nadeem, Sheikh F Ahmad, Naif O Al-Harbi, et al.
International Journal of Nanomedicine|October 14, 2024
Current Updates of CRISPR/Cas System and Anti-CRISPR Proteins: Innovative Applications to Improve the Genome Editing StrategiesKhaled S Allemailem, Ahmad Almatroudi, Faris Alrumaihi, et al.
Plos One|August 16, 2023
Albendazole repurposing on VEGFR-2 for possible anticancer application: In-silico analysisNikita Maruti Gaikwad, Pravin Digambar Chaudhari, Karimunnisa Sameer Shaikh, et al.
Molecular Immunology|February 27, 2022
CCR1 antagonist ameliorates experimental autoimmune encephalomyelitis by inhibition of Th9/Th22-related markers in the brain and peripheryHaneen A Al-Mazroua, Ahmed Nadeem, Mushtaq A Ansari, et al.
Pageof 8